Although the GLUT4 expression level is directly related to the glucose uptake capacity of insulin target tissues, researchers have not confirmed whether agents that are able to enhance GLUT4 expression would possess therapeutic effects on IR or T2DM. This evidence concerns the gene SLC2A4 and type 2 diabetes mellitus.